Webinars

Introducing ISMP's New Targeted Best Practices for 2018-2019

to

Join ISMP for a complimentary webinar as we seek to inspire and mobilize practitioners from around the US in the national adoption of specific consensus-based safe practices selected to reduce or eliminate the repetitive medication safety issues that continue to cause fatal and harmful errors to patients.

During this FREE webinar, learn about ISMP’s three new Targeted Medication Safety Best Practices for Hospitals and why they were selected for national action. This call to action includes new targets on the use of injectable promethazine, fentaNYL patches, and the use of external error information for advancing safety. Our speaker will also provide an update on the national progress with implementation of ISMP’s eleven Targeted Medication Safety Best Practices from 2016-2017; giving participants the opportunity to weigh in on their current level of adoption. Don’t miss this opportunity to join this important call and align your safety practices.


Intended Audience:

  • Hospital and Health System Leadership
  • Quality and Risk Management Leaders
  • Physician, Pharmacy, and Nursing Leaders
  • Medication Safety and Patient Safety Officers
  • Frontline Practitioners

Learning Objectives:

Following completion of this activity, participants will be able to:

  1. Cite the three most implemented, and three least implemented best practices from the 2016-2017 list of ISMP Targeted Medication Safety Best Practices for Hospitals.
  2. Describe recommended strategies to overcome common implementation barriers for ISMP’s Targeted Medication Safety Best Practices.
  3. Identify the three new best practices for 2018-2019 and the medication errors that each of these new best practices were designed to prevent.

Introduction and Overview:

Allen Vaida, PharmD, FASHP, Executive Vice President, ISMP

Speaker(s):

Darryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist, ISMP

Price:

Free

This activity is funded through an educational grant from Novartis.

View Activity


CE Accreditation

No continuing education credits are available for this activity.

Experts

More Webinars